There are more than a dozen telehealth providers offering compounded GLP-1 medications under $200/month. Quality varies dramatically. We scored each one on four criteria: monthly price (40% weight), pharmacy sourcing and quality (25%), clinical oversight (20%), and pricing transparency (15%). Here are the results.
The Rankings
| Rank | Provider | Price/mo | Score | Pharmacy | Key Strength |
|---|---|---|---|---|---|
| 🥇 1 | GobyMeds | $99 | 92/100 | 503A + 503B | Lowest price + LegitScript |
| 🥈 2 | Oak Longevity | $130 | 88/100 | Licensed | Flat rate + free coaching |
| 🥉 3 | Embody* | $149 first | 85/100 | 503B | Metabolic report + 100K pts |
| 4 | Gala GLP-1 | $179 | 84/100 | Licensed | Dose-locked flat pricing |
| 5 | Care Bare Rx | $169 | 81/100 | Licensed | Wellness-led care model |
| 6 | BB Health+ | $179 | 80/100 | Licensed | Bodybuilding.com backed |
| 7 | BiltRx | See pricing | 79/100 | Licensed | Broad medication access |
| 8 | Yucca Health | $149+ | 78/100 | Licensed | BNPL financing options |
| 9 | MEDVi | $175 | 72/100 | Licensed | Oral options available |
| 10 | Wellorithm | See pricing | 71/100 | Licensed | Personalized protocols |
* Embody ranks #3 overall but drops to #6 on price alone ($299/mo ongoing). Score reflects the full clinical package value.
⚠️ MEDVi received an FDA Warning Letter in February 2026. Score reflects this regulatory concern.
Why GobyMeds Ranks #1
GobyMeds hits every scoring criterion hard: the lowest price on the board ($99/month flat), dual 503A and 503B pharmacy sourcing (the gold standard for compounding quality), LegitScript certification (the same verification Google and Facebook require for healthcare advertisers), free consultation and shipping with no hidden fees, and both semaglutide ($99) and tirzepatide ($133) available. The only area where GobyMeds doesn't lead is clinical depth — the consultation model is functional but less structured than Embody's 1:1 guidance.
The Sub-$150 Tier
Three providers occupy the aggressive pricing tier under $150/month: GobyMeds ($99), Oak Longevity ($130), and Embody's first month ($149). Of these, only GobyMeds and Oak maintain that price long-term — Embody jumps to $299 from month 2. If your budget ceiling is $150/month at maintenance, your real choices are GobyMeds and Oak Longevity.
Oak Longevity: The Runner-Up
Oak Longevity offers semaglutide at $130/month and tirzepatide at $199/month — both flat-rate at any dose. The included free coaching adds clinical value that GobyMeds doesn't match. The $31/month premium over GobyMeds buys you that structured support. For patients who want a middle ground between GobyMeds' lean model and Embody's premium experience, Oak is the sweet spot.
The $150-$200 Tier
This crowded tier includes Care Bare Rx ($169), Gala ($179), BB Health+ ($179), MEDVi ($175), and Yucca Health ($149+ depending on plan). Differentiation here is about features: Gala's dose-locked pricing (you'll never pay more as you titrate up), Yucca's Klarna/Afterpay financing, and Care Bare's wellness-focused approach.
Providers We Excluded and Why
Several providers advertise sub-$200 pricing but didn't make the ranked list due to transparency issues, unverifiable pharmacy sourcing, or promotional pricing that increases dramatically after the first month. If a provider's "real" price at maintenance dose exceeds $200/month, they don't qualify for this ranking regardless of their advertised first-month price.